Earth Science Tech, Inc. Liquidation Value

ETST Pharmaceuticals

Cash & Equivalents

$415,699
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $415,699
Total Obligations: -$2.28M
$-1.86M
Per share: $-0.01
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $415,699
AR: $306,118
Total Obligations: -$2.28M
$-1.56M
Per share: $-0.01
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $415,699
AR: $306,118
Inventory: $1.09M
Total Obligations: -$2.28M
$-468,341
Per share: $-0.00
Period: 2025-12-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Finance Lease Liability: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-1.86M$-0.01
Liquid Liquidation Value$-1.56M$-0.01
Operating Liquidation Value$-468,341$-0.00

Key Components (as of 2025-12-31)

Data as of 2025-12-31 from 10-Q filed 2026-02-13. View on SEC EDGAR →

Cash & Equivalents$415,699
Accounts Receivable$306,118
Inventory$1.09M
Current Liabilities$2.26M
Long-term Debt (?)N/A
Op. Lease Liability (?)$18,177
Finance Lease (?)N/A
Shares Outstanding291.6M

Explore all 127 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$415,699$306,118$1.09M$1.09M$2.26MN/A$18,177N/A
2025-09-30$2.47M$227,189$1.04M$1.05M$3.55MN/A$23,879N/A
2025-06-30$1.76M$341,644$811,859$960,062$3.40MN/A$70,571N/A
2025-03-31$607,620$129,064$503,938$492,352$3.15MN/A$37,878N/A
2024-12-31$1.04M$164,221$137,557$46,292$2.31M$42,785$70,190N/A
2024-09-30$3.06M$203,942$432,217$392,227$1.70MN/A$100,690N/A
2024-06-30$2.77M$317,687$239,174$221,030$1.48MN/A$67,524N/A
2024-03-31$1.40M$235,423$315,738$530,724$1.49M$60,559$84,950N/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-Q 2026-02-13 View
2025-09-30 10-Q 2025-11-12 View
2025-06-30 10-Q 2025-08-08 View
2025-03-31 10-K 2025-06-27 View
2024-12-31 10-Q/A 2025-02-18 View
2024-12-31 10-Q 2025-02-14 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-07-29 View

AI Insights

AI Insight·Generated 2026-05-05

Earth Science Tech, Inc. (ETST) is a Florida-domiciled holding company operating compounding pharmacies (RxCompound, Mister Meds), telemedicine platforms (Peaks, DOConsultations), a brick-and-mortar health clinic (Villas), real estate/investment management (Avenvi), and a 75% interest in MagneChef. Period end: December 31, 2025 (Q3 FY2026, nine months ended). Prior period compared: September 30, 2025 (Q2 FY2026).

Under the liquidation lens, the recovery posture is modestly positive in aggregate book equity ($5.8M stated) but becomes negative once standard haircuts are applied. Rough liquidation math: Cash $416K (100% = $416K); AR $306K (90% = $275K); Equity investments at fair value $1.13M (Level 1, 90% = $1.02M, reflecting execution risk); Inventory $1.09M (60% = $653K); PP&E net $1.89M (60% = $1.13M, mix of land, building, land improvements, furniture/equipment); ROU asset $139K (0%); Intangibles net $378K (0%); Goodwill $2.65M (0%); Deposits/Prepaid ~$97K (50% = $49K). Estimated gross liquidation proceeds approximately $3.54M. Total liabilities at face: $2.29M (includes $140K operating lease obligations, $39K equipment loan, $1.09M AP, $1.02M accrued expenses). Net liquidation recovery to equity approximately +$1.25M before winding costs, transaction friction, and any priority claims. MFFAIS-reported CLV of -$1.86M reflects a more conservative asset haircut methodology; the difference is largely attributable to treatment of the equity investment portfolio and PP&E.

Key drivers of recovery posture: (1) Goodwill of $2.65M and intangibles net $378K carry zero liquidation value — together they represent 37% of total assets and are the primary drag. (2) The Level 1 equity investment portfolio ($1.13M) is the most liquid non-cash asset and is realizable near par minus execution costs. (3) Liability stack is relatively light and short-duration — total liabilities decreased $929K QoQ from $3.22M (March 31, 2025) to $2.29M at December 31, 2025, driven by a $1.4M reduction in accrued officer compensation from $1.81M to $416K. (4) Inventory roughly doubled QoQ from $504K to $1.09M, increasing the haircut drag. (5) Goodwill increased to $2.65M due to April 1, 2025 acquisitions of Las Villas/DOConsultations ($118K goodwill) and Magnefuse ($228K goodwill), plus a BBQraft trademark acquisition ($173K intangibles) subsequently sold back January 1, 2026 per Note 13. (6) Operating cash flow declined to $1.06M for the nine months vs $2.38M in the comparable prior year period, driven by inventory build ($518K cash use), AR increase ($177K), and working capital shifts. (7) The $10M share repurchase program (Avenvi-managed) is an ongoing cash commitment not separately reflected as a contingent liability in the balance sheet.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...